<DOC>
	<DOCNO>NCT00500006</DOCNO>
	<brief_summary>This study evaluate MK0457 combination Dasatinib patient Chronic Myelogenous Leukemia Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia . Efficacy Safety evaluate .</brief_summary>
	<brief_title>A Phase I Dose Escalation Combination Study Patients With Chronic Myelogenous Leukemia ( CML ) Philadelphia Chromosome-Positive ( Ph+ ) Acute Lymphoblastic Leukemia ( ALL ) ( 0457-009 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Philadelphia Chromosome</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>Patients must chronic myelogenous leukemia ( CML ) Philadelphia chromosomepositive acute lymphoblastic leukemia ( Ph+ ALL ) Patients must least 3 month start dasatinib therapy currently receive dasatinib therapy CML Ph+ ALL evaluable hematologic response prior enter study Patient able treat 70 mg bid dose dasatinib without significant toxicity time study entry Patients active CNS disease include may treat concurrently intrathecal therapy per institutional standard Patient treatment antileukemia therapy ( investigational approve ) dasatinib precede 3 month . Pheresis hydroxyurea treatment precede 3 month exclude patient eligibility Patient unresolved equal grade 2 clinically significant toxicity attribute dasatinib time study entry Patient know hypersensitivity component study drug analog Patient pregnant breastfeeding , expect conceive within project duration study Patient symptomatic ascites , pericardial pleural effusion . A patient clinically stable follow treatment condition eligible Patient prior radiation therapy 10 % bone marrow ; patient must recover least 3 week hematologic toxicity prior radiotherapy Patient LVEF &lt; 40 % multigated radionucleotide angiography ( MUGA ) echocardiography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>